Vista, CA, United States of America

Kottani Rudresha

This inventor holds 1 USPTO granted patent. Top assignee: Auspex Pharmaceuticals, Inc.. Active years: 2009.


Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2009

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Kottani Rudresha: Innovator in Pharmaceutical Chemistry

Introduction

Kottani Rudresha is a notable inventor based in Vista, CA (US). He has made significant contributions to the field of pharmaceutical chemistry through his innovative research and development efforts. His work focuses on the preparation of heterocyclic molecules that have various applications in pharmaceuticals, cosmeceuticals, agrochemicals, and industrial uses.

Latest Patents

Kottani Rudresha holds 1 patent for a method of preparation of heterocyclic molecules. This patent describes processes for preparing racemic and optically pure 3,6-dihydro-2H-pyrans of specific formulae. These compounds can be further transformed into other compounds with potential applications in pharmaceuticals, pharmaceutical excipients, cosmeceuticals, agrochemicals, and industrial sectors.

Career Highlights

Kottani Rudresha is currently associated with Auspex Pharmaceutical, Inc., where he continues to advance his research in pharmaceutical chemistry. His work has been instrumental in developing new methodologies that enhance the efficacy and safety of pharmaceutical products.

Collaborations

He has collaborated with esteemed colleagues such as Borcherng Hong and Zhong-Yi Chen, contributing to a dynamic research environment that fosters innovation and discovery.

Conclusion

Kottani Rudresha's contributions to the field of pharmaceutical chemistry exemplify the impact of innovative research on the development of new therapeutic solutions. His work continues to pave the way for advancements in various applications, showcasing the importance of creativity and collaboration in scientific endeavors.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…